semaglutide effect on liver Focus 2.4 mg/week for the Treatment of Metabolic Dysfunction‐Associated Steatohepatitis Frontiers | Glucagon-like peptide-1 and
Description
Sch, L
doi: 10.1056/NEJMoa2032183 [DOI] [PubMed] [Google Scholar] 5
Beyond traditional GLP-1RAs, dual and emerging multi-agonists may have additional metabolic and renal implications
AGEs are a result of the glycation reaction between glucose and proteins, nucleic acids and lipids
Despite the abundance of GLP-1 research, studies in UC have been less consistent, especially body weight
Benoit-Marand M, Borrelli E, Gonon F
